XML 160 R119.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting - Sales of Company's Products (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Sales $ 64,168 $ 60,115 $ 59,283
Increase (decrease) in revenue hedging activities 195 244 810
Revenue related to the sale of the marketing rights 106 118 165
Operating Segments      
Segment Reporting Information [Line Items]      
Sales 63,277 59,208 57,555
Operating Segments | Pharmaceutical      
Segment Reporting Information [Line Items]      
Sales 57,400 53,583 52,005
Operating Segments | Pharmaceutical | Keytruda      
Segment Reporting Information [Line Items]      
Sales 29,482 25,011 20,937
Operating Segments | Pharmaceutical | Alliance revenue - Lynparza      
Segment Reporting Information [Line Items]      
Sales 1,311 1,199 1,116
Operating Segments | Pharmaceutical | Alliance revenue - Lenvima      
Segment Reporting Information [Line Items]      
Sales 1,010 960 876
Operating Segments | Pharmaceutical | Welireg      
Segment Reporting Information [Line Items]      
Sales 509 218 123
Operating Segments | Pharmaceutical | Alliance revenue - Reblozyl      
Segment Reporting Information [Line Items]      
Sales 371 212 166
Operating Segments | Pharmaceutical | Gardasil/Gardasil 9      
Segment Reporting Information [Line Items]      
Sales 8,583 8,886 6,897
Operating Segments | Pharmaceutical | ProQuad/M-M-R II/Varivax      
Segment Reporting Information [Line Items]      
Sales 2,485 2,368 2,241
Operating Segments | Pharmaceutical | Vaxneuvance      
Segment Reporting Information [Line Items]      
Sales 808 665 170
Operating Segments | Pharmaceutical | RotaTeq      
Segment Reporting Information [Line Items]      
Sales 711 769 783
Operating Segments | Pharmaceutical | Pneumovax 23      
Segment Reporting Information [Line Items]      
Sales 263 412 602
Operating Segments | Pharmaceutical | Bridion      
Segment Reporting Information [Line Items]      
Sales 1,764 1,842 1,685
Operating Segments | Pharmaceutical | Prevymis      
Segment Reporting Information [Line Items]      
Sales 785 605 428
Operating Segments | Pharmaceutical | Dificid      
Segment Reporting Information [Line Items]      
Sales 340 302 263
Operating Segments | Pharmaceutical | Zerbaxa      
Segment Reporting Information [Line Items]      
Sales 252 218 169
Operating Segments | Pharmaceutical | Noxafil      
Segment Reporting Information [Line Items]      
Sales 177 213 238
Operating Segments | Pharmaceutical | Winrevair      
Segment Reporting Information [Line Items]      
Sales 419 0 0
Operating Segments | Pharmaceutical | Alliance revenue - Adempas/Verquvo      
Segment Reporting Information [Line Items]      
Sales 415 367 341
Operating Segments | Pharmaceutical | Adempas      
Segment Reporting Information [Line Items]      
Sales 287 255 238
Operating Segments | Pharmaceutical | Lagevrio      
Segment Reporting Information [Line Items]      
Sales 964 1,428 5,684
Operating Segments | Pharmaceutical | Isentress/Isentress HD      
Segment Reporting Information [Line Items]      
Sales 394 483 633
Operating Segments | Pharmaceutical | Delstrigo      
Segment Reporting Information [Line Items]      
Sales 249 201 151
Operating Segments | Pharmaceutical | Pifeltro      
Segment Reporting Information [Line Items]      
Sales 163 142 118
Operating Segments | Pharmaceutical | Belsomra      
Segment Reporting Information [Line Items]      
Sales 222 231 258
Operating Segments | Pharmaceutical | Simponi      
Segment Reporting Information [Line Items]      
Sales 543 710 706
Operating Segments | Pharmaceutical | Remicade      
Segment Reporting Information [Line Items]      
Sales 114 187 207
Operating Segments | Pharmaceutical | Januvia      
Segment Reporting Information [Line Items]      
Sales 1,334 2,189 2,813
Operating Segments | Pharmaceutical | Janumet      
Segment Reporting Information [Line Items]      
Sales 935 1,177 1,700
Operating Segments | Pharmaceutical | Other pharmaceutical      
Segment Reporting Information [Line Items]      
Sales 2,510 2,333 2,462
Operating Segments | Animal Health      
Segment Reporting Information [Line Items]      
Sales 5,877 5,625 5,550
Operating Segments | Animal Health | Livestock      
Segment Reporting Information [Line Items]      
Sales 3,462 3,337 3,300
Operating Segments | Animal Health | Companion Animal      
Segment Reporting Information [Line Items]      
Sales 2,415 2,288 2,250
Other      
Segment Reporting Information [Line Items]      
Sales 891 907 1,728
United States      
Segment Reporting Information [Line Items]      
Sales 32,277 28,480 27,206
United States | Operating Segments      
Segment Reporting Information [Line Items]      
Sales 32,151 28,343 26,811
United States | Operating Segments | Pharmaceutical      
Segment Reporting Information [Line Items]      
Sales 30,290 26,539 24,989
United States | Operating Segments | Pharmaceutical | Keytruda      
Segment Reporting Information [Line Items]      
Sales 17,872 15,114 12,686
United States | Operating Segments | Pharmaceutical | Alliance revenue - Lynparza      
Segment Reporting Information [Line Items]      
Sales 626 607 584
United States | Operating Segments | Pharmaceutical | Alliance revenue - Lenvima      
Segment Reporting Information [Line Items]      
Sales 705 657 579
United States | Operating Segments | Pharmaceutical | Welireg      
Segment Reporting Information [Line Items]      
Sales 466 209 123
United States | Operating Segments | Pharmaceutical | Alliance revenue - Reblozyl      
Segment Reporting Information [Line Items]      
Sales 303 168 123
United States | Operating Segments | Pharmaceutical | Gardasil/Gardasil 9      
Segment Reporting Information [Line Items]      
Sales 2,425 2,083 2,065
United States | Operating Segments | Pharmaceutical | ProQuad/M-M-R II/Varivax      
Segment Reporting Information [Line Items]      
Sales 1,919 1,837 1,724
United States | Operating Segments | Pharmaceutical | Vaxneuvance      
Segment Reporting Information [Line Items]      
Sales 461 561 163
United States | Operating Segments | Pharmaceutical | RotaTeq      
Segment Reporting Information [Line Items]      
Sales 472 493 508
United States | Operating Segments | Pharmaceutical | Pneumovax 23      
Segment Reporting Information [Line Items]      
Sales 56 127 346
United States | Operating Segments | Pharmaceutical | Bridion      
Segment Reporting Information [Line Items]      
Sales 1,401 1,156 922
United States | Operating Segments | Pharmaceutical | Prevymis      
Segment Reporting Information [Line Items]      
Sales 371 264 188
United States | Operating Segments | Pharmaceutical | Dificid      
Segment Reporting Information [Line Items]      
Sales 303 274 241
United States | Operating Segments | Pharmaceutical | Zerbaxa      
Segment Reporting Information [Line Items]      
Sales 146 119 89
United States | Operating Segments | Pharmaceutical | Noxafil      
Segment Reporting Information [Line Items]      
Sales 7 32 51
United States | Operating Segments | Pharmaceutical | Winrevair      
Segment Reporting Information [Line Items]      
Sales 408 0 0
United States | Operating Segments | Pharmaceutical | Alliance revenue - Adempas/Verquvo      
Segment Reporting Information [Line Items]      
Sales 388 350 329
United States | Operating Segments | Pharmaceutical | Adempas      
Segment Reporting Information [Line Items]      
Sales 0 0 0
United States | Operating Segments | Pharmaceutical | Lagevrio      
Segment Reporting Information [Line Items]      
Sales 176 10 1,523
United States | Operating Segments | Pharmaceutical | Isentress/Isentress HD      
Segment Reporting Information [Line Items]      
Sales 185 215 274
United States | Operating Segments | Pharmaceutical | Delstrigo      
Segment Reporting Information [Line Items]      
Sales 56 49 39
United States | Operating Segments | Pharmaceutical | Pifeltro      
Segment Reporting Information [Line Items]      
Sales 113 101 87
United States | Operating Segments | Pharmaceutical | Belsomra      
Segment Reporting Information [Line Items]      
Sales 72 81 79
United States | Operating Segments | Pharmaceutical | Simponi      
Segment Reporting Information [Line Items]      
Sales 0 0 0
United States | Operating Segments | Pharmaceutical | Remicade      
Segment Reporting Information [Line Items]      
Sales 0 0 0
United States | Operating Segments | Pharmaceutical | Januvia      
Segment Reporting Information [Line Items]      
Sales 469 1,151 1,248
United States | Operating Segments | Pharmaceutical | Janumet      
Segment Reporting Information [Line Items]      
Sales 161 223 355
United States | Operating Segments | Pharmaceutical | Other pharmaceutical      
Segment Reporting Information [Line Items]      
Sales 729 658 663
United States | Operating Segments | Animal Health      
Segment Reporting Information [Line Items]      
Sales 1,861 1,804 1,822
United States | Operating Segments | Animal Health | Livestock      
Segment Reporting Information [Line Items]      
Sales 732 700 710
United States | Operating Segments | Animal Health | Companion Animal      
Segment Reporting Information [Line Items]      
Sales 1,129 1,104 1,112
United States | Other      
Segment Reporting Information [Line Items]      
Sales 126 137 395
Int’l      
Segment Reporting Information [Line Items]      
Sales 31,891 31,635 32,077
Int’l | Operating Segments      
Segment Reporting Information [Line Items]      
Sales 31,126 30,865 30,744
Int’l | Operating Segments | Pharmaceutical      
Segment Reporting Information [Line Items]      
Sales 27,110 27,044 27,016
Int’l | Operating Segments | Pharmaceutical | Keytruda      
Segment Reporting Information [Line Items]      
Sales 11,610 9,897 8,251
Int’l | Operating Segments | Pharmaceutical | Alliance revenue - Lynparza      
Segment Reporting Information [Line Items]      
Sales 685 592 532
Int’l | Operating Segments | Pharmaceutical | Alliance revenue - Lenvima      
Segment Reporting Information [Line Items]      
Sales 305 303 297
Int’l | Operating Segments | Pharmaceutical | Welireg      
Segment Reporting Information [Line Items]      
Sales 43 10 0
Int’l | Operating Segments | Pharmaceutical | Alliance revenue - Reblozyl      
Segment Reporting Information [Line Items]      
Sales 68 43 43
Int’l | Operating Segments | Pharmaceutical | Gardasil/Gardasil 9      
Segment Reporting Information [Line Items]      
Sales 6,158 6,803 4,832
Int’l | Operating Segments | Pharmaceutical | ProQuad/M-M-R II/Varivax      
Segment Reporting Information [Line Items]      
Sales 566 531 518
Int’l | Operating Segments | Pharmaceutical | Vaxneuvance      
Segment Reporting Information [Line Items]      
Sales 347 103 7
Int’l | Operating Segments | Pharmaceutical | RotaTeq      
Segment Reporting Information [Line Items]      
Sales 239 276 275
Int’l | Operating Segments | Pharmaceutical | Pneumovax 23      
Segment Reporting Information [Line Items]      
Sales 207 285 256
Int’l | Operating Segments | Pharmaceutical | Bridion      
Segment Reporting Information [Line Items]      
Sales 363 686 762
Int’l | Operating Segments | Pharmaceutical | Prevymis      
Segment Reporting Information [Line Items]      
Sales 414 341 240
Int’l | Operating Segments | Pharmaceutical | Dificid      
Segment Reporting Information [Line Items]      
Sales 37 28 22
Int’l | Operating Segments | Pharmaceutical | Zerbaxa      
Segment Reporting Information [Line Items]      
Sales 106 100 79
Int’l | Operating Segments | Pharmaceutical | Noxafil      
Segment Reporting Information [Line Items]      
Sales 170 181 187
Int’l | Operating Segments | Pharmaceutical | Winrevair      
Segment Reporting Information [Line Items]      
Sales 11 0 0
Int’l | Operating Segments | Pharmaceutical | Alliance revenue - Adempas/Verquvo      
Segment Reporting Information [Line Items]      
Sales 27 16 12
Int’l | Operating Segments | Pharmaceutical | Adempas      
Segment Reporting Information [Line Items]      
Sales 287 255 238
Int’l | Operating Segments | Pharmaceutical | Lagevrio      
Segment Reporting Information [Line Items]      
Sales 787 1,418 4,161
Int’l | Operating Segments | Pharmaceutical | Isentress/Isentress HD      
Segment Reporting Information [Line Items]      
Sales 209 268 359
Int’l | Operating Segments | Pharmaceutical | Delstrigo      
Segment Reporting Information [Line Items]      
Sales 193 152 111
Int’l | Operating Segments | Pharmaceutical | Pifeltro      
Segment Reporting Information [Line Items]      
Sales 50 41 30
Int’l | Operating Segments | Pharmaceutical | Belsomra      
Segment Reporting Information [Line Items]      
Sales 150 150 179
Int’l | Operating Segments | Pharmaceutical | Simponi      
Segment Reporting Information [Line Items]      
Sales 543 710 706
Int’l | Operating Segments | Pharmaceutical | Remicade      
Segment Reporting Information [Line Items]      
Sales 114 187 207
Int’l | Operating Segments | Pharmaceutical | Januvia      
Segment Reporting Information [Line Items]      
Sales 865 1,039 1,565
Int’l | Operating Segments | Pharmaceutical | Janumet      
Segment Reporting Information [Line Items]      
Sales 774 954 1,344
Int’l | Operating Segments | Pharmaceutical | Other pharmaceutical      
Segment Reporting Information [Line Items]      
Sales 1,782 1,675 1,803
Int’l | Operating Segments | Animal Health      
Segment Reporting Information [Line Items]      
Sales 4,016 3,821 3,728
Int’l | Operating Segments | Animal Health | Livestock      
Segment Reporting Information [Line Items]      
Sales 2,729 2,637 2,590
Int’l | Operating Segments | Animal Health | Companion Animal      
Segment Reporting Information [Line Items]      
Sales 1,287 1,184 1,138
Int’l | Other      
Segment Reporting Information [Line Items]      
Sales $ 765 $ 770 $ 1,333